Kos’ Niaspan/Simvastatin Combination NDA Planned For 2006
This article was originally published in The Pink Sheet Daily
Executive Summary
Two pivotal trials for the extended-release niacin/simvastatin fixed-dose combination are underway, Kos says. Firm expects the new combo to be superior to predecessor Advicor in lowering LDL-cholesterol and similar in raising HDL-C.